Figure 3From: Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancerKaplan-Meier estimates of the prognostic impact of KRAS mutation according to histological subtype. Kaplan-Meier analysis of ovarian cancer specific survival according to KRAS mutation status in (A) mucinous, (B) serous and (C) endometrial tumours.Back to article page